28
Participants
Start Date
March 5, 2009
Primary Completion Date
November 14, 2012
Study Completion Date
November 14, 2012
Infliximab
Intravenous repeating dose
Methotrexate
Oral or parenteral repeating dose
Methylprednisolone
Intravenous repeating dose
Ocrelizumab
Intravenous repeating dose
Placebo
Intravenous repeating dose
Arthritis & Osteoporosis Center, Brooklyn
Regional Clinical Research, Binghamton
Buffalo Rheumatology Associates, Orchard Park
Southern Tier Arthritis & Rheumatism, Olean
Arthritis Associates, Erie
Lehigh Valley Physicians Group, Allentown
Barada,Harrell,Toohey&Bellhorn, Durham
Physicians East Pa, Greenville
Columbia Arthritis Center (Partnership Practice), Columbia
South Carolina Research Center, Myrtle Beach
Piedmont Arthritis Clinic, Greenville
Harbin Clinic, Rome
Arthritis Res & Treatment, Macon
Rheumatology Associates of Central Florida, Orlando
Science and Research Institute, Inc., Jupiter
RASF-Clinical Research Center, Boca Raton
Lovelace Scientific Resources, Sarasota
Robert W. Levin MD - PP, Dunedin
Rheumatology Associates, Birmingham
Ctr for Inflammatory Disease, Nashville
Arthritis Associates, Hixson
Ramesh Gupta - PP, Memphis
Arthritis Associates of Mississippi, Jackson
Jackson Arthritis Clinic, Flowood
Graves Gilbert Clinic, Bowling Green
Ohio State Univ Med Center, Columbus
Shores Rheumatology, Saint Clair Shores
Hurley Medical Center, Flint
Fiechtner Research Inc, Lansing
Rheumatology, P.C.; Medical Arts Building, Kalamazoo
Billings Clinic; Research Center, Billings
Billings Clinic, Billings
Illinois Bone & Joint Inst., Morton Grove
Springfield Clinic, Springfield
Private Practice - Rosenberg, Florissant
Clayton Medical Research, St Louis
University of Kansas Medical Center, Kansas City
Westroads Medical Group, Omaha
NEA Baptist Clinic, Jonesboro
Oklahoma Medical Research Foundation, Oklahoma City
Healthcare Research Consultants, Tulsa
Southwest Rheumatology, Mesquite
Phillip A Waller MD, PA, Houston
Texas Arthritis Research Center, San Antonio
Amarillo Center For Clinical Research, Amarillo
Arthritis Assoc & Osteoporosis; Ctr of Colorado Springs, Colorado Springs
Institute of Arthritis Research, Idaho Falls
Arthritis Center of Reno, Reno
Agilence Arthritis and Osteoporosis Medical Center, Inc., Whittier
Dr. Brigid Freyne, MD, Murrieta
Providence Arthritis Center, Portland
Clinical Pharmacology Study Group, Worcester
Dartmouth-Hitchcock Medical Center, Rheumatology 5C, Lebanon
Lead Sponsor
Genentech, Inc.
INDUSTRY